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Drug abuse has expanded from more well-known substances, such as cocaine and 
marijuana, to relatively new novel psychoactive substances. A group of these substances called 
synthetic cannabinoids have been increasing in usage throughout the 2000's, and these 
compounds carry significant and varying risks depending on the dose and composition of the 
synthetic cannabinoid. Patients have been observed having symptoms associated with high doses 
of synthetic cannabinoids when they take lower doses of the synthetic cannabinoid in addition to 
their antidepressant medication. In order to test the etlects of co-administration of selective 
serotonin reuptake inhibitors (SSRis) and synthetic cannabinoids, mice were observed in a 
marble burying assay under the influence of the different drugs. Mice were given either 
fluoxetine (1 0-mg/kg), citalopram (20-mg/kg), or JWH-0 18 (0.1-mg/kg or 0.3-mg/kg) or a 
combination of the drugs. Mice without being injected with any of the drugs bw-ied 6.375 
marbles on average in the twenty-minute test. Mice injected with fluoxetine or citalopram alone 
buried 4.25 marbles and 4.0 marbles respectively. The JWH-018 doses were chosen to be 
ineffective so that the marbles buried at 0.1-mg/kg was 6.125 and the 0.3-mg/kg dose resulted in 
6.375 marbles buried. Fluoxetine in combination with JWH-018 resulted in 3.0 marbles being 
buried for the lower dose and 1.875 marbles were buried with the high dose. Citalopram in 
combination with JWH-0 18 resulted in 3.625 marbles buried for the lower dose and 2.875 
marbles buried for the high dose. When the SSRis were taken with an ineffective dose of JWH-
0 18 a greater than anticipated drug effect occwTed, since it occurred in both combinations it 
points to a phannacodynamic effect instead of a phatmacokinetic effect. 
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Background 
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There are approximately two hundred scheduled drugs internationally, but there are over 
seven hundred other substances that are available. These drugs are called new psychoactive 
substances and are largely unregulated (National Institute of Abuse, 20 15). These substances 
include but are not limited to both synthetic cathinones and synthetic cannabinoids. Both of 
these groups are becoming increasingly prevalent in drug abuse and are significant risks to public 
health, especially in young people (Office of Drug Control Policy). 
In the past few years synthetic drugs have been in the news more frequently. The use of 
synthetic cathinones, also known as bath salts, has led to dramatized news reports of individuals 
involved in grisly acts of violence against others (ABC News, 2012). Synthetic cannabinoids on 
the other hand have not seen as many sensationalized news articles, which adds to a perception 
of safety that abusers see in the drugs. Abusers also see that marijuana is beginning to be 
legalized and used medically, so people think the synthetic cannabinoids are "synthetic 
mruijuana", a safe and legal alternative. In a 2012 Monitoring the Future Survey, 11.3% ofhigh 
school seniors reported using some type of synthetic cannabinoids (National Institute of Abuse, 
20 15). On the other hand, bath salts are perceived as more dangerous so only 1.3% of high 
school seniors repmted having used bath salts (Seeley et al., 20 13). 
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Figure 1: Active Ingredient in Marijuana, A9-THC 
One of the most dangerous aspects of synthetic cathinones is the different effects that 
can occur from different derivatives. Synthetic cathinones have been known to mimic the effects 
of several big name illicit drugs for example methylenedioxypyrovaJerone (tviDPV) mimics the 
effects of cocaine. Other cathinones seem to be similar to MDMA (ecstasy) and 
methamphetamine. Synthetic carmabinoids on the other hand are seen only as "fake weed" but it 
has varying effects similar to synthetic cathinones. 
The ability of synthetic cannabinoids to have multiple effects is problematic for 
healthcare. For example, in Brunswick, Georgia dming late August and early September 2013 
twenty-two patients were admitted to emergency departments for synthetic cannabinoid use. 
Patients experienced a variety of symptoms from the drug abuse including hyperglycemia, 
hyperkalemia; acidosis, tachycardia, nausea, vomiting, confusion or disorientation, aggression, 
unresponsiveness and seizures. Some ofthese patients experienced complications of pneumonia 
(two), rhabdomyolysis (one), and myocardial infarctions (one). Certain patients were admitted to 
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intensive care units and some required assisted ventilation. The huge variety of effects that 
resulted from synthetic cannabinoid use for these patients resulted from the same product, called 
"Crazy Clown", that was bought from the same smoke shop (Dreznek, 20 13). 
This example is only the effects of one synthetic cannabinoid product from one smoke 
shop in one state. The United Kingdom National Poisons Information Service (UKNPIS) used a 
survey that lasted for eight years to identify different effects that have resulted from synthetic 
cannabinoid abuse. In addition to the variety of effects that were seen in Georgia, the UK survey 
uncovered symptoms such as abdominal pain, chest pain, hypotension, arrhythmia, speech 
disorders, and more (Waugh, et al, 2016). The increase in symptoms found by the UKNPTS may 
be a function of different products, since the most popular synthetic cannabinoid products in the 
survey were Black Mamba, Clockwork Orange, and Pandora's Box, not Crazy Clown (Waugh, 
et al, 20 16). 
Synthetic cannabinoid products that are sold, such as K2, Spice, or Crazy Clown, are 
unpredictable because they can contain one or many different synthetic cannabinoids. The reason 
synthetic drugs can be easily altered by changing only side groups on the original chemical 
resulting in many compounds that have varying effects. Figure 2 shows how many different 
synthetic cannabinoids, each of which has a slightly different structure and slightly different 
effects (Tai and Fantegrossi , 2016). The ease in which the drug composition can change helps 
people to avoid drug enforcement. The tests for drugs are typically done by taking blood or 
urine samples followed by immunoassays and mass spectrometry assays. The problem is that 
assays are too specific to identify all of the new compounds. Antibodies for immunoassays are 
too specific and even if we had less specific antibodies that could identify the main components 
of synthetic cannabinoids the mass spectrometry would still need to be specific. The mass 
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spectrometry needs the initial structure and its metabolites to work which with many of these 
synthetic cannabinoids isn't possible. The mass spectrometry is required as a confirmation in 
case the immunoassay results in a false positive. Without it the whole test is ineffective 






Pharmucologicol and To.xicological Effects of Synthetic Cannabinoids and71tt!ir Metabolites. Tai and Fantegrossi 2016. 
Figure 2: Variety of Synthetic Cannabinoids 
Another problem that occurs with synthetic cannabinoids is that they can be more 
efficacious and potent than marijuana. Figure 3 illustrates how two synthetic cannabinoids are 
more efficacious than marijuana. Efficacy is the ability of a compound to bind the receptor, 
because for a drug to be effective it has to be able to bind the receptor. In Figure 2 the lines of 
best fit for JWH-018 and JWH-073 are both shifted to the left of the Jine of best fit for THC, 
which is the active compound in marijuana. The shift to the left means that it takes less substrate 
(on the horizontal access) to have the same amount of receptor binding as THC, therefore the 
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Figure 3: Comparative Receptor Binding Affinity 
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Figure 4 also shows how the same two drugs are more efficacious, but in a different way. 
Once the CaiJllabinoid binds to the receptor it activates a G-protein that then causes a signal 
cascade in the cell. The G-protein activation of JWH-018 and JWH-073 are shifted left ofTHC, 
but JWH-073 is much less obvious in this graph. The shift left again means that less substrate is 
needed for the synthetic cannabinoids to bjnd to the cannabinoid receptors and therefore means it 
is more efficacious. The Jines of best fit for G-protein activation for the two synthetic 
cannabinoids are also shifted vertically on the graph, which means that for the same amount of 
substrate the synthetic cannabinoid has a greater effect. This increase in effect is referred to as 
the potency of the drug, so the synthetic cannabinoids are more potent than THC. 
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Figure 4: Comparative G-Protein Activation 
The increase in efficacy and potency of synthetic cannabinoids as opposed to THC is 
where the increased likelihood of negative health effects lies. The effect of marijuana and many 
medicines has been tested and is mostly well known, but synthetic cannabinoids could interact 
with drugs that marijuana does not. Rumors of patients coming into hospitals with high dose 
effects of synthetic cannabinoids when taking low doses of synthetic cannabinoids with selective 




General Hypotheses. Synthetic cannabinoids when co-administrated with SSRis will 
result in a larger than anticipated drug effect. The larger than anticipated drug effect resulting 
from the co-administration will be due to a pharmacokinetic effect involving the enzymatic 
breakdown of the two compounds. 
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Experimental Hypotheses. An ineffective dose of JWH-018 when co-administered with 
an effective dose of the SSRI fluoxetine will result in less marbles buried than with only 
fluoxetine. The larger than anticipated drug effect will be due to a pharmacokinetic effect 
involving the cytochrome 2C9 that breaks down both fluoxetine and JWH-018. 
Methods 
All methods were canied out as recommended by the Public Health Service Policy on 
Humane Care and Use of Laboratory Animals ofthe National Institute of Health. The protocols 
were approved by the Department of Laboratory Animal Medicine at the University of Arkansas 
for the Medical Sciences. 
Protocols. 
1. Standard plastic mouse cages were used for the marble burying test. Fresh standard 
bedding added to the cages from 3-cm to 5-cm in depth. Plastic filter tops were placed on 
cages to prevent mice from escaping during the tests. Wire racks that hold food and water 
were withheld during the tests. 
2. Ten standard glass marbles arranged on top of the bedding approximately equidistant in 
the same pattern for every cage (see Figure 6). Before the marbles were placed in the 
cages, they were cleaned and dried to remove scents of earlier experiments. 
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3. Stopwatches were set for twenty minutes, but results were checked and recorded every 
five minutes. 
4. Each mouse was injected intraperitoneally before the test with the dose depending on the 
compound( s) being tested. Then the mouse was given a treatment time to allow the 
effects of the drug to occur, which was also dependent on the compound injected. 
The Laboratory Mouse. Unffl<r.vity of llfinois at Chicago, 20 I 4. 
Figure 5: Intraperitoneal Injection of Mouse 
5. A single mouse was then set into each cage and left undisturbed for twenty minutes. 
After the twenty minutes the mice were returned to their home cages. 
6. The marbles were then examined and those that were buried over half their height were 
counted. 
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Figure 6: Example Marble Burying Test with Saline 
Figure 7: Example Marble Burying Test with SSRJ 
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Pre-Experiment. Before the main experiments began there were several tests to ensure 
that the marble burying assay would work for the planned experiment. Firstly, the SSRis 
fluoxetine was tested at the dose 10-mg/kg with a thirty-minute treatment time to give a baseline 
effect of the SSRis. Then citalopram was tested at 10-mg/kg and 20-mg/k.g with treatment times 
of thirty-minute and one-hour treatment times in order to fmd an effect that was similar to the 
effect of fluoxetine at 1 0-mg/kg. The 20-mg/kg dose was chosen to be used for the later tests 
with a treatment time of thirty-minutes. The chosen doses of fluoxetine and citalopram had 
nearly equivalent effects on marble burying, but if the JWH-018 interacted in later test~ we 
would still be able to see change in either direction (agonistic or antagonistic interaction effects). 
Then tests were run to confirm the ineffective doses of .JWH-018 from 0.1-mg/kg, 0.3-
mg/kg and 1.0-mg/kg with a thirty-minute treatment t ime. Both 0.1-mg/kg and 0.3-mg/kg were 
found to have no effect on the marble burying test, but the 1.0-mg/kg dose was eliminated due to 
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Figme 8: Repeated Saline Trials 
The final pre-experiment test was to find if the marble burying test could be used 
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repeatedly without having an effect on results. This would determine if the same mice could be 
used in a longitudinal experiment, so that they could be used as controls against themselves. In 
order to test that we gave a group of 8 mice saline injections, and then they were subjected to the 
marble burying test. The same group of 8 mice repeated this test with saline from between 10:00 
am and 12:00 pm every day for six days. The results of all 8 mice were averaged for each day 
and the results were recorded in Figure 8. 1bere was no significant difference in the results of 
tests over the course of the six days, so we decided to continue with the longitudinal experiment 
design. 
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Experiment. The main experiment was run with eight mice, which were included in all 
of the tests. The design of the experiment was longitudinal, meaning that the same mice were 
used over a relatively long period of time so that the results of earlier tests can be used as 
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Figure 9: Longitudinal Experiment Design 
Combintation 
Drug Test 
First the mice went through two control tests. The first control test was with no drug to 
see what a mouse would normally do when presented with the marbles. Then the second test 
was with saline in order to see if discomfort or aggravation from the injection would change the 
results of the marble burying test. These tests were used as a baseline to compare the results of 
the drugs later tested as can be seen in Figure 1 0. 
The day after the control testing was finished, the SSRl drugs were tested. The first test 
was with the 1 0-mg/kg dose of tluoxetine with a thirty-minute treatment time, and then the mice 
were tested with 20-mg/kg of citalopram with a thirty-minute treatment time. These tests allowed 
us to have a baseline drug effect for SSRTs to compare with our interaction tests. Between the 
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tests with the SSRI injections two days of saline tests were run in order to allow each drug time 
to washout. This prevented residual drugs in the mouse from influencing the results of later 
experiments. 
After the SSRI tests and the final two-day washout period for them, the mice began the 
two JWH-018 tests. The tirst test was with JWH-018 at 0.3-mglkg with a thirty-minute 
treatment time. Two days of saline tests were then administered. After the washout period the 
second test was nm with JWH-0 18 at 0.1-mg/kg with a thirty-minute treatment time. The two 
synthetic cannabinojd tests were run in order to confirm that the doses did not affect the marble 
burying test in the same way as it did in previous tests. 
After the final JWH -0 18 test the mice were again given a two-day washout period before 
beginning the final portion of the experiments. The next tests conducted were the JWH-0 I 8 0.3-
mg/kg dose with the two doses of SSRJs. First the SSRI was injected and immediately afterward 
the JWH-018 dose was injected into the mouse. After the mouse was injected a thirty-minute 
treatment time was observed before the mice began the marble burying test. Between each 
combination test the same two-day washout period was observed. After the high dose of JWH-
018 was tested, the same was done for the 0.1-mg/k.g dose. 
Post Experiment. After the tests in the main experiment were completed an additional 
test was run to give additional data on whether an interaction discovered would be 
pharmacokinetic or phannacodynamic. In the test, the mice were given the 0.3-mg/kg dose of 
JWH-018, a 10-mg/kg dose offluoxetine, and a 10-mg/kg dose ofrimonabant. The antagonist 
rimonabant was added to the test to block any pharmacodynamic effect, so if there was no 
change to marble burying the interaction was pharmacokinetic, but if there was a change with the 
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Figure 10: Average Marbles Buried for Various Treatments 
When the mice were given only saline the mice buried on average 6.375 marbles. When 
mice were injected with the O.l~mglkg dose of JWH-018 6.125 marbles were buried on average 
and at 0.3-mg/kg 6.375 marbles were buried on average. Neither of these values reflects a 
significant difference from the saline control group. The fluoxetine dose of 1 O~mg/kg resulted in 
an average of 4.25 marbles buried, and the citalopram dose of20-mg/kg resulted in an average of 
4.0 marbles buried. Both of the SSRis caused the marble burying to decrease significantly from 
the control group. The SSRI effects are not significantly different than each other. Fluoxetine in 
combination with both doses of JWH-018 caused a decrease in marble burying. The combination 
offluoxetine with the 0.1-mg/kg dose of JWH-018 resulted in 3.0 marbles being buried on 
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average, and the 0.3-mg/kg dose of JWH-0 18 resulted in 1.875 marbles being buried on average. 
The citalopram combination was not as successful as the fluoxetine combination, but a decrease 
also occurred. The citalopram and 0.1-mg/kg dose of JWH-018 caused an average of3.625 
marbles to be buried, which is not significantly different the citalopram test. The 0.3-mg/kg of 
JWH-018 combination was significantly different at 2.875 marbles buried. These results can be 
seen graphically in Figure 10. 
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Figure 11 : Marbles Buried for Rimonabant Combination 
Figure 11 shows the results of the last test that occurred after the main experiment had 
ended. The first bar is the same control as was used in the original experiment, 6.375 marbles 
buried. The second bar is the 1 0-mg/kg fluoxetine result from the previous experiment ( 4.25 
18 
marbles buried), and the third bar is the combination of 0.3-mg/kg JWH-0 18 and fluoxetine from 
the previous experiment (1.875 marbles buried). The final bar was the same 0.3-mg/k.g JWH-
0 18 and 1 0-mg/k.g fluoxetine combination as before, but 1 0-mg/kg rimonabant was added to the 
combination. When rimonabant was added to the experiment, the amount of marbles buried was 
3.375. 
Conclusions 
Co-administration of JWH-018 and both SSRls, fluoxetine and citalopram, resulted in a 
greater than anticipated drug effect as was hypothesized. The increased drug effect with the 
synthetic cannabinoid and fluoxetine was expected, but it was not expected to occur with 
citalopram. Citalopram was a positive control, since it did not share the same enzyme as the 
other two compounds, which means that there is likely a pharmacodynamic aspect to the 
increased drug effect. The evidence that the effect is pharmacodynamic goes against the initial 
hypothesis. Also, the results of the rimonabant experiment support a pharmacodynamic 
interaction, since the inclusion of rimonabant reduced the additional effect of the combination. 
These results are significant since they illustrate how co-administration of the two types 
of compounds can result in high dose effects at low doses. The greater breadth of increased 
effect than expected will also warrant more tests with a variety of SSRls and other anti-
depressant medication. It will also mean that the increase in synthetic cannabinoid abuse with 
common prescription drugs may resu1t in more hospitalizations or potential deaths. 
There are many futme experiments that could be useful in examining the interaction 
between these drugs. First, having more trials of the current tests would help to validate what 
has already been done, but changing from a longitudinal experiment design could be helpfuL 
Mice could be used in a control test and then two other tests before being replaced. This would 
19 
help to eliminate any changes in marble burying that occurred due to tolerance, sensitivity or 
dependence. Mice being used for a shorter time would al so help increase the sample size, which 
would help prevent outliers from skewing any results. 
Tests that examined the effects of chronic use of these compounds could also be 
interesting. Either JWH-018 or an SSRI could be given chronically then an acute injection of the 
other drug could be given with a treatment time before the marble burying test is administered. 
SSRis are taken daily, so it would be relevant to see the chronic effects. Synthetic cannabinoids 
can also be abused chronicaliy, so giving either drug chronically before an acute injection would 
be relevant. 
More testing is imperative so that more information can be observed regarding the effects 
of synthetic cannabinoids and SSRls together. SSRis are already one of the most commonly 
prescribed types of antidepressants, and synthetic cannabinoids abuse has been increasing for 
years. The use of these drugs together can cause many negative health em~L'fs, but continued tests 
such as these can help prepare for abuse of these drugs in the future. 
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